Recent Finacing
Recent Raise
Alder Biopharmaceuticals develops and manufactures monoclonal antibody therapeutics for cancer, pain, cardiovascular, autoimmune and inflammatory conditions, using a yeast-based platform for scalable full-length antibody production.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
